ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 168 filers reported holding ACCELERON PHARMA INC in Q2 2019. The put-call ratio across all filers is 1.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $1,231,000 | +37.1% | 7,154 | 0.0% | 0.01% | +25.0% |
Q2 2021 | $898,000 | -7.4% | 7,154 | 0.0% | 0.00% | -20.0% |
Q1 2021 | $970,000 | +6.0% | 7,154 | 0.0% | 0.01% | +25.0% |
Q4 2020 | $915,000 | +13.7% | 7,154 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $805,000 | +18.0% | 7,154 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $682,000 | +6.1% | 7,154 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $643,000 | +273.8% | 7,154 | +120.4% | 0.00% | +300.0% |
Q4 2019 | $172,000 | +34.4% | 3,246 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $128,000 | -3.8% | 3,246 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $133,000 | -11.9% | 3,246 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $151,000 | +7.1% | 3,246 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $141,000 | -24.2% | 3,246 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $186,000 | +18.5% | 3,246 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $157,000 | +23.6% | 3,246 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $127,000 | -8.0% | 3,246 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $138,000 | – | 3,246 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,080,113 | $50,301,000 | 4.98% |
Foresite Capital Management II, LLC | 188,602 | $8,783,000 | 3.96% |
Artal Group S.A. | 1,650,000 | $76,841,000 | 3.14% |
Foresite Capital Management III, LLC | 254,923 | $11,872,000 | 3.09% |
Asymmetry Capital Management, L.P. | 30,125 | $1,403,000 | 2.34% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,255,174 | $58,453,000 | 2.24% |
QVT Financial LP | 190,977 | $8,894,000 | 2.24% |
SECTORAL ASSET MANAGEMENT INC | 269,396 | $12,546,000 | 1.51% |
Novo Holdings A/S | 198,261 | $9,233,000 | 1.37% |
FARALLON CAPITAL MANAGEMENT LLC | 2,375,000 | $110,604,000 | 0.83% |